VVP
ABBV icon

Venture Visionary Partners’s AbbVie ABBV Stock Holding History

Venture Visionary Partners’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$9.79M Sell
37,423
-1,265
-3% -$324K 0.26% 101
2026
Q2 		$9.74M Buy
38,688
+4,003
+12% +$861K 0.27% 96
2026
Q1 		$7.54M Buy
34,685
+1,230
+4% +$273K 0.25% 106
2025
Q4 		$7.75M Sell
33,455
-31
-0.1% -$7.06K 0.25% 100
2025
Q3 		$7.75M Sell
33,486
-2,284
-6% -$465K 0.27% 96
2025
Q2 		$6.64M Sell
35,770
-8,593
-19% -$1.6M 0.25% 99
2025
Q1 		$9.3M Sell
44,363
-2,322
-5% -$451K 0.39% 66
2024
Q4 		$8.3M Buy
46,685
+1,917
+4% +$352K 0.35% 73
2024
Q3 		$8.84M Sell
44,768
-276
-0.6% -$51.5K 0.38% 74
2024
Q2 		$7.73M Buy
45,044
+687
+2% +$114K 0.36% 77
2024
Q1 		$8.08M Sell
44,357
-540
-1% -$93.1K 0.38% 72
2023
Q4 		$6.96M Buy
44,897
+395
+0.9% +$57.6K 0.37% 77
2023
Q3 		$6.63M Sell
44,502
-479
-1% -$70.3K 0.4% 69
2023
Q2 		$6.06M Buy
44,981
+987
+2% +$145K 0.36% 77
2023
Q1 		$7.01M Buy
43,994
+924
+2% +$141K 0.44% 62
2022
Q4 		$6.96M Sell
43,070
-738
-2% -$113K 0.5% 50
2022
Q3 		$5.88M Buy
43,808
+1,366
+3% +$196K 0.48% 53
2022
Q2 		$6.5M Buy
42,442
+809
+2% +$124K 0.49% 49
2022
Q1 		$6.75M Sell
41,633
-25,232
-38% -$3.67M 0.45% 58
2021
Q4 		$9.09M Buy
66,865
+3,566
+6% +$421K 0.59% 43
2021
Q3 		$6.85M Buy
63,299
+4,054
+7% +$463K 0.49% 50
2021
Q2 		$6.68M Buy
59,245
+3,486
+6% +$393K 0.54% 40
2021
Q1 		$6.03M Buy
55,759
+21,814
+64% +$2.33M 0.5% 44
2020
Q4 		$3.64M Buy
33,945
+22,382
+194% +$2.15M 0.4% 54
2020
Q3 		$1.05M Buy
11,563
+1,888
+20% +$178K 0.26% 59
2020
Q2 		$949K Buy
9,675
+2,545
+36% +$224K 0.28% 53
2020
Q1 		$543K Buy
7,130
+3,351
+89% +$285K 0.2% 74
2019
Q4 		$334K Buy
+3,779
New +$314K 0.1% 121

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
SC
Sapient Capital Indianapolis, Indiana $7.44B AUM 23.27% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
IWA
Inspirion Wealth Advisors Libertyville, Illinois $880M AUM 10.53% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return

Venture Visionary Partners's ABBV Position: Q3 2026 in Review

Venture Visionary Partners reduced its AbbVie (ABBV) stake by 3.3% in Q3 2026, selling an estimated $324K and leaving 37,423 shares worth $9.79M. The position accounts for 0.26% of the portfolio, ranked #101.

Venture Visionary Partners first reported a position in ABBV in Q4 2019 and has held it in 28 quarters since. 246 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Venture Visionary Partners held 37,423 shares of AbbVie worth $9.79M as of Q3 2026.
  • Venture Visionary Partners sold 1,265 AbbVie shares in Q3 2026, an estimated $324K.
  • AbbVie made up 0.26% of Venture Visionary Partners's portfolio in Q3 2026, its #101 holding.
  • Venture Visionary Partners first reported a position in AbbVie in Q4 2019 and has held it in 28 quarters since.
  • 246 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Venture Visionary Partners's 13F filing for Q3 2026, filed 7 Oct 2026.